MedTrace Logo

Identifying and Characterizing Preclinical MS

NCT05787795 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-11-14

No results posted yet for this study

Summary

The purpose of this research study is to try and identify risk factors and biologic changes that suggest that someone may go on to develop multiple sclerosis before a person has shown any symptoms of the disease.

Conditions

Interventions

OTHER

biological samples

blood draw, oral swab, optional stool samples, spinal fluid sample, fat biopsy, tonsil biopsy, lymph node tissue sample, MRI

Sponsors & Collaborators

  • Roche-Genentech

    collaborator INDUSTRY

  • Yale University

    lead OTHER

Principal Investigators

  • Erin Longbrake, MD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2032-06-30
Completion
2033-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05787795 on ClinicalTrials.gov